These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22635102)

  • 41. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
    Watt AD; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity.
    Greenough MA; Volitakis I; Li QX; Laughton K; Evin G; Ho M; Dalziel AH; Camakaris J; Bush AI
    J Biol Chem; 2011 Mar; 286(11):9776-86. PubMed ID: 21239495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
    Cuajungco MP; Fagét KY
    Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.
    Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN
    Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.
    Schrag M; Mueller C; Oyoyo U; Smith MA; Kirsch WM
    Prog Neurobiol; 2011 Aug; 94(3):296-306. PubMed ID: 21600264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies.
    Strodel B; Coskuner-Weber O
    J Chem Inf Model; 2019 May; 59(5):1782-1805. PubMed ID: 30933519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
    Yokel RA
    J Alzheimers Dis; 2006 Nov; 10(2-3):223-53. PubMed ID: 17119290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zinc and Copper in Alzheimer's Disease.
    Avan A; Hoogenraad TU
    J Alzheimers Dis; 2015; 46(1):89-92. PubMed ID: 25835420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Metals in Alzheimer's Disease: An Update.
    Du B; Chen K; Wang W; Lei P
    J Alzheimers Dis; 2024; 101(s1):S141-S154. PubMed ID: 39422951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is brain iron trafficking part of the physiology of the amyloid precursor protein?
    Bailey DK; Kosman DJ
    J Biol Inorg Chem; 2019 Dec; 24(8):1171-1177. PubMed ID: 31578640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Copper and oxidative stress in the pathogenesis of Alzheimer's disease.
    Eskici G; Axelsen PH
    Biochemistry; 2012 Aug; 51(32):6289-311. PubMed ID: 22708607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper in the brain and Alzheimer's disease.
    Hung YH; Bush AI; Cherny RA
    J Biol Inorg Chem; 2010 Jan; 15(1):61-76. PubMed ID: 19862561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.
    Graham SF; Nasaruddin MB; Carey M; Holscher C; McGuinness B; Kehoe PG; Love S; Passmore P; Elliott CT; Meharg AA; Green BD
    J Alzheimers Dis; 2014; 42(4):1407-13. PubMed ID: 25024342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The essential elements of Alzheimer's disease.
    Lei P; Ayton S; Bush AI
    J Biol Chem; 2021; 296():100105. PubMed ID: 33219130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer's Disease.
    Singh R; Panghal A; Jadhav K; Thakur A; Verma RK; Singh C; Goyal M; Kumar J; Namdeo AG
    Mol Neurobiol; 2024 Dec; 61(12):10916-10940. PubMed ID: 38809370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
    Squitti R
    J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.
    Pal A; Kumar A; Prasad R
    Biometals; 2014 Feb; 27(1):25-31. PubMed ID: 24435851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
    J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.